Company / AR per Share
Apellis Pharmaceuticals, Inc. AR per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$2.94
FY2025
5-year range
$0.08 / $2.94
FY2021-FY2025
Trend
+32.8%
vs FY2024
Sector context
#35 of 113
Health Care
What the data says
At $2.94, Apellis Pharmaceuticals, Inc.'s ar per share ranks #35 of 113 in the Health Care sector. AR per Share has increased for 3 consecutive years, from $0.08 in FY2022 to $2.94 in FY2025.
Based on SEC 10-K filings.
2.94 in FY2025 with a 3-year CAGR of +233.6%.
Improved from $1.86 to $2.94 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +233.6%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#35 of 113 in Health CareTop 31% of 113This company $2.94 Sector average $28.83
▼
-89.8% below sector average
Key checks
Key Insights
- Apellis Pharmaceuticals, Inc.'s ar per share has grown for 3 consecutive years.
- In FY2025, ar per share increased 32.8% year-over-year.
- Ranks #35 out of 113 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -0.60 (distress zone, below 1.8 threshold)
- Negative profit margin: -25.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.94 | +32.8% |
| FY2024 | $2.22 | +18.9% |
| FY2023 | $1.86 | +2252.2% |
| FY2022 | $0.08 | -40.3% |
| FY2021 | $0.13 | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026